Molecular, Cellular, and Blood Biomarkers in Diagnosis, Prognosis, Monitoring, and Treatment
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 29
Special Issue Editors
Interests: oxidative stress; inflammation; metabolism; non-communicable diseases; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Interests: Oxidative stress
Special Issue Information
Dear Colleagues,
Biomarkers are pivotal in modern medicine, serving as vital clues that unlock the mysteries of diseases. By detecting subtle molecular, cellular, or biochemical changes, biomarkers enable early diagnosis, personalized treatment strategies, and precise monitoring of therapeutic responses. They revolutionize patient care by enhancing accuracy, efficiency, and patient outcomes. Biomarkers also drive drug discovery, guiding the development of targeted therapies and facilitating clinical trials. In essence, biomarkers illuminate the path towards a future of healthcare where interventions are precisely tailored to individual needs, leading to improved quality of life and better health outcomes for all. Presently, biomarker research occupies the focal point where biology and medicine converge.
By contributing to this Special Issue, you will have the opportunity to share your findings on the latest developments in molecular, cellular, and blood biomarkers. This platform also offers a unique opportunity for collaboration and networking with fellow researchers in this field. Whether you are exploring cancer signatures, unraveling neurodegenerative disease pathways, or investigating the biomarkers of any other non-communicable or infectious disease, your work has the potential to impact patient care. Moreover, your contributions will help advance diagnostic tools, prognostic models, monitoring techniques, and targeted therapies.
We encourage scientists like you to send original research articles and reviews that will cover any aspect of the effects of molecular, cellular, and blood biomarkers in diagnosis, prognosis, monitoring, and treatment. Your unique perspectives and insights are invaluable in our collective effort to translate research into tangible benefits for patients. Together, we can make a significant difference in patient care.
Dr. Jordi Camps
Dr. Isabel Fort Gallifa
Dr. Xavier Gabaldó Barrios
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- infectious diseases
- laboratory medicine
- non-communicable diseases
